27-Oct-2026 21:18:55

PIRAMAL PHARMA Q2 : Management says Strong H1FY27 performance and continued business momentum have strengthened visibility for the remainder of the year.

We are therefore raising our FY27 outlook and now anticipate 19-20% revenue growth with meaningfully higher profitability.

PIRAMAL PHARMA LIMITED